Alongside the concept of BM “crowding out” by tumor cells, it has been demonstrated that hematopoietic stem and progenitor cells (particularly erythroid precursors) may be reduced from the functional impairment, which has been tied to the adverse tumor ME, and particularly TGFβ signaling [31]. This evidence concerns the gene TGFB1 and neoplasm.